Yale Cancer Center researchers were awarded a five-year, $11.7 million grant from NIH to fund the Yale Head and Neck Cancer Specialized Program of Research Excellence.
The goal of the Yale Head and Neck Cancer SPORE is to address critical barriers to treatment of head and neck squamous cell carcinoma due to resistance to immunotherapy, DNA damaging, and targeted therapy.
The YHN-SPORE is a collaboration with Fox Chase Cancer Center and the University of North Carolina Lineberger Cancer Center, and is one of three SPOREs awarded to YCC.
